LAMEA Sexually Transmitted Diseases (STD) Testing Market Size, Share & Industry Trends Analysis Report By Disease Type, By the Location of Testing, By Country, Historical Data and Growth Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Sexually Transmitted Diseases (STD) Testing Market
Market Report Description
The Latin America, Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market would witness market growth of 6.7% CAGR during the forecast period (2021-2027).
The demand for STD testing is predicted to increase as a result of recommendations from various regulatory bodies for annual STD screening for sexually active men and women. STD screening services are now widely covered by health-care plans, which would likely boost the worldwide STD testing market's growth. For example, under the Affordable Care Act in the United States, STD screening treatments are covered without cost-sharing. STD prevention and control techniques have been specified by regulatory bodies like the World Health Organization.
The prevalence of STDs or STIs are gaining a high momentum in the African region, which is leading to various health problems and serious complications. When compared to other regions, Sub-Saharan Africa has the highest annual STD cases. Infections with the herpes simplex virus and the human papillomavirus are becoming more common in Sub-Saharan Africa. While there are more than 20 bacteria that cause STDs, they mostly manifest themselves in four syndromes and can thus be treated syndromically. Many government and major healthcare organizations are working together to improve the state of medical services, especially STD treatment across this region.
The Brazil market dominated the LAMEA Sexually Transmitted Diseases (STD) Testing Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $2.48 billion by 2027. The Argentina market is poised to grow at a CAGR of 7.3% during (2021 - 2027). Additionally, The UAE market would showcase CAGR of 6.4% during (2021 - 2027).
Based on Disease Type, the market is segmented into Chlamydia, Herpes simplex, Gonorrhea, Syphilis, Human papillomavirus (HPV), and Other Disease. Based on the Location of Testing, the market is segmented into Laboratory Testing and Point of care (POC) Testing. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin Molecular LLC, Danaher Corporation, Bio-Rad Laboratories, Inc., and OraSure Technologies, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Disease Type
- Herpes simplex
- Human papillomavirus (HPV)
- Other Disease
By Location of Testing
- Laboratory Testing
- Point of care (POC) Testing
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- BioMérieux S.A.
- Abbott Laboratories
- Becton, Dickinson and Company
- Hologic, Inc.
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- DiaSorin Molecular LLC
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- OraSure Technologies, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free